Chimera Research Group

clinical trial catalysts. Our coverage may also include mid-to-large cap biopharma companies where there exists specific catalysts. Where appropriate, our recommended trade and investment ideas incorporate the use of simple to more complex option strategies. Our coverage universe is continuously updated and includes research and trade/investment ideas for the Top 10 up-and-coming catalysts that represent the best opportunities for traders and investors. The biopharmaceutical sector offers significant opportunities to generate big returns yet can be risky and difficult to navigate. Subscribe to Chimera Research Group and proceed with confidence.

sponsoring company's stock price. This "ultimate catalyst event" provides smart, organized & nimble option traders spectacular & consistent trading opportunities. In this unique book, the author provides individuals unfamiliar with the world of small cap biotech a fast, simplified and efficient approach to identify, analyze & execute trading strategies using options. The following topics, amongst others, are covered in this book: * Description of the FDA drug trial process, from pre-clinical to Phase III & beyond * Identification, categorization & organization of small cap biotech companies * Structured & streamlined approach to assess small cap biotech companies * Notes on trading strategy & tactics * Detailed description of option trading structures best suited for small cap biotech This book is an absolute "must have" for individuals thinking about trading in the fast paced and often confusing world of small cap biotech.